Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion type Assertion NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_head.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion wasGeneratedBy ECO_0000203 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion wasDerivedFrom befree-2016 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion SIO_000772 23550022 NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion evidence source_evidence_literature NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.
- NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_assertion description "[Discovery of tyrosine kinase inhibitors targeting the BCR-ABL1 kinase revolutionized CML therapy, but these drugs are unable to eradicate the disease due to the presence of a drug-insensitive stem cell population that sustains continued growth of the malignant cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065807.RAxkQngcG1F2DC0sWbAo0POdEqiPqCpbW7lZgOOZeas4Y130_provenance.